Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
336
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
-759K
-
Total reported value, excl. options
-
$5.05B
-
Value change
-
+$16.7M
-
Put/Call ratio
-
1.64
-
Number of buys
-
174
-
Number of sells
-
-153
-
Price
-
$42.60
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2025
411 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2025.
Guardant Health, Inc. - Common Stock (GH) has 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 124M outstanding shares and own 95.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (12.1M shares), BlackRock, Inc. (11.2M shares), Deep Track Capital, LP (5.44M shares), Capital International Investors (5.15M shares), BAILLIE GIFFORD & CO (5.06M shares), CADIAN CAPITAL MANAGEMENT, LP (4.6M shares), CITADEL ADVISORS LLC (3.6M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.57M shares), GEODE CAPITAL MANAGEMENT, LLC (2.91M shares), and STATE STREET CORP (2.8M shares).
This table shows the top 336 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.